OGIVRI 150 mg subst sèche flac perf 1 pce
7680674670018
CH-67467
L01FD01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6746701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- trastuzumabum 150 mg, histidinum, histidini hydrochloridum monohydricum, macrogolum 3350, sorbitolum 115.2 mg, acidum hydrochloridum, natrii hydroxidum, pro vitro corresp. natrium 0.07 mg.
Articles (1)
Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
trastuzumabum
|
150.0 MG | Substance | Wirkstoff (Principe actif) |
|
histidinum
|
- | Substance | HNIDK |
|
histidini hydrochloridum monohydricum
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
sorbitolum
|
115.2 MG | Substance | HBESI |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
natrium
|
0.07 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 513.25
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2020
Authorization holder
Medius AG
4132 Muttenz
Authorization information
- Swissmedic authorization number
- 67467
- Drug name
- Ogivri 150 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- LSPA
- ATC Code
- L01FD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 02/04/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- OGIVRI 150 mg subst sèche flac perf 1 pce
- Description (DE)
- OGIVRI 150 mg Trockensub 1 Durchstf 1 Stk
- Market launch
- 02/04/2020
- Narcotic (BTM)
- No